Since cancer cells have been found to synthesize de novo fatty acids in excess [54], and prostate cancer becomes aggressive with overexpression of fatty acid synthase [55], suppressing the levels of de novo fatty acids by elevated ANO7 may offer a mechanism to limit cancerous lipogenesis. Here, FASN is linked to cancer.